[Epidermophytoses and Candida mycoses. Treatment and prevention of recurrence].
D000666:Amphotericin B / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D002177:Candidiasis / Q000188:drug therapy / Q000517:prevention & control*; D006118:Griseofulvin / Q000627:therapeutic use; D006801:Humans; D009761:Nystatin / Q000627:therapeutic use; D012008:Recurrence; D014005:Tinea / Q000188:drug therapy / Q000517:prevention & control*; D014008:Tinea Pedis / Q000188:drug therapy; D014047:Tolnaftate / Q000627:therapeutic use
D000935:Antifungal Agents; D014047:Tolnaftate; D009761:Nystatin; D006118:Griseofulvin; D000666:Amphotericin B
Epidermophytien und Candida-Mykosen. Behandlung und Rezidivprophylaxe